Veeva Systems Inc. (VEEV) Stock Valuation — PE Analysis

Software - Application · NYSE

Current Price

$207.91

PE Ratio (TTM)

36.1x

Intrinsic Value

$268.52

+22.6% margin of safety

AI MOAT & RISK ANALYSIS
AI Generated · For Reference OnlyVEEV

COMPETITIVE MOAT

Deep Life Sciences Ecosystem Lock-in

Veeva's integrated suite of cloud solutions for the life sciences industry creates significant switching costs. Customers are deeply embedded in its platform for critical functions like CRM and R&D.

Network Effects in Data and Collaboration

The more life sciences companies use Veeva's platform, the more valuable its data and collaborative features become. This network effect strengthens its competitive position.

Specialized Industry Expertise and Data

Veeva possesses deep, specialized knowledge of the highly regulated life sciences sector. This allows it to build tailored solutions and leverage proprietary data that competitors struggle to replicate.

INVESTMENT RISKS

Intensifying Competition in Cloud Solutions

The life sciences cloud market is attractive, and Veeva faces competition from established tech giants and specialized players looking to capture market share.

Regulatory Scrutiny in Healthcare Data

As a custodian of sensitive healthcare data, Veeva is subject to stringent and evolving regulatory requirements, which could increase compliance costs and operational complexity.

Execution Risk of AI and Acquisition Integration

Successfully integrating acquired companies like Copli and effectively deploying new AI technologies like Falcon MLR are critical for future growth and carry inherent execution risks.

Base case

VEEV base case PE valuation

A base case PE valuation for VEEV estimates a fair value of about $268.52 per share, against a current price of $207.91. The model assumes 13.0% annual earnings growth, a 36x target PE multiple, and a 10% discount rate.

Intrinsic Value

$268.52

Margin of safety

+22.6%

Expected annual return

+5.2%

Base case assumptions: 13.0% annual earnings growth, 36x target PE, 10% discount rate, 5 year projection. Data as of 2026-07-29.

This base case uses default assumptions and is not financial advice. The fair value changes significantly when the target PE or earnings growth rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.

Customize the VEEV PE valuation

Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Veeva Systems Inc. respond.

Open PE Calculator for VEEV

Or try DCF Valuation for VEEV

Company Overview

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.

Financial Metrics — VEEV PE Stock Valuation Data

PE Ratio (TTM)

36.1x

PEG Ratio

1.83

Earnings Yield

2.77%

ROE (TTM)

13.4%

Revenue/Share (TTM)

$20.32

Debt/Equity

0.01x

Frequently Asked Questions

What is the PE ratio of VEEV?

The trailing twelve-month PE ratio of VEEV reflects how much investors pay per dollar of Veeva Systems Inc.'s earnings. This metric is most useful when compared to Software - Application peers and the company's own historical range.

Is VEEV overvalued based on PE ratio?

VEEV's PE of 36.1x combined with a PEG ratio of 1.83 provides a growth-adjusted perspective. A PEG near 1.0 means the P/E is roughly in line with the earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Software - Application, a DCF analysis may be more appropriate.

How do I value VEEV stock using PE ratio?

To value Veeva Systems Inc. using PE: (1) Compare the current PE (36.1x) against the Software - Application median to assess relative pricing, (2) check the PEG ratio (1.83) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.

What is the PEG ratio of VEEV?

VEEV's PEG ratio is 1.83, calculated by dividing the PE ratio (36.1x) by the expected earnings growth rate. A PEG near 1.0 means the P/E is roughly in line with the expected earnings growth rate. Note that PEG accuracy depends on the reliability of growth estimates.

Should I use PE ratio or DCF for VEEV stock valuation?

PE ratio gives a quick relative read — how VEEV is priced versus Software - Application peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.

Learn More

Related PE Valuations

All Technology valuations

P/E and DCF value VEEV with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.

Price as of 2026-07-29. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.

This is an estimate, not investment advice.